FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage

Despite Medicare coverage, drug may remain out of reach for many patients, policy experts say
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.